Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2026-07-02 17:21:17 ET · period of report 2026-07-01 · accession 0001853529-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-02 17:21 | 2026-07-01 | EWTX | Russell Alan J | CSO, Dir | M - OptEx | $0.356 | +200.0K | 224.6K | +814% | +$71.2K |
| DMT | 2026-07-02 17:21 | 2026-07-01 | EWTX | Russell Alan J | CSO, Dir | S - Sale+OE | $39.41 | -200.0K | 24.6K | -89% | -$7.88M |
| DMT | 2026-07-02 17:21 | 2026-07-01 | EWTX | Russell Alan J | CSO, Dir | M - OptEx | $0.00 | -200.0K | 1.08M | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-01 | M | A | 130,352 | $0.45 | 154,907 | D | — | — | (F1) Includes 107 shares purchased on November 15, 2025 and 1,048 shares purchased on May 15, 2026 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2026-07-01 | M | A | 69,648 | $0.18 | 224,555 | D | — | — | |
| 3 | Common | Common Stock | 2026-07-01 | S | D | 130,352 | $39.41 | 94,203 | D | — | — | (F2) The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $38.77 to $40.81, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2026-07-01 | S | D | 69,648 | $39.41 | 24,555 | D | — | — | (F3) The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $38.77 to $40.905, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-07-01 | M | D | 130,352 | $0.00 | 0 | D | $0.45 · — to 2028-08-30 | 130,352 Common Stock | (F4) 1/48th of the shares subject to the option vest each month beginning on September 10, 2018, subject to the Reporting Person continuing as a service provider through each vest date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-07-01 | M | D | 69,648 | $0.00 | 1,077,717 | D | $0.18 · — to 2032-06-27 | 69,648 Common Stock | (F5) 1/48th of the shares subject to the option vest each month beginning on July 27, 2017, subject to the Reporting Person continuing as a service provider through each vest date. |